Success Metrics

Clinical Success Rate
100.0%

Based on 58 completed trials

Completion Rate
100%(58/58)
Active Trials
3(4%)
Results Posted
12%(7 trials)

Phase Distribution

Ph phase_3
3
4%
Ph early_phase_1
1
1%
Ph phase_4
8
10%
Ph not_applicable
52
65%
Ph phase_1
6
8%
Ph phase_2
9
11%

Phase Distribution

7

Early Stage

9

Mid Stage

11

Late Stage

Phase Distribution79 total trials
Early Phase 1First-in-human
1(1.3%)
Phase 1Safety & dosage
6(7.6%)
Phase 2Efficacy & side effects
9(11.4%)
Phase 3Large-scale testing
3(3.8%)
Phase 4Post-market surveillance
8(10.1%)
N/ANon-phased studies
52(65.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

96.7%

58 of 60 finished

Non-Completion Rate

3.3%

2 ended early

Currently Active

3

trials recruiting

Total Trials

80

all time

Status Distribution
Active(5)
Completed(58)
Terminated(2)
Other(15)

Detailed Status

Completed58
unknown15
Not yet recruiting2
Recruiting2
Withdrawn2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
80
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (1.3%)
Phase 16 (7.6%)
Phase 29 (11.4%)
Phase 33 (3.8%)
Phase 48 (10.1%)
N/A52 (65.8%)

Trials by Status

not_yet_recruiting23%
recruiting23%
completed5873%
active_not_recruiting11%
withdrawn23%
unknown1519%

Recent Activity

Clinical Trials (80)

Showing 20 of 80 trialsScroll for more
NCT00798226Phase 1

Fish Oil Supplementation During Pregnancy for Prevention of Asthma, Eczema and Allergies in Childhood

Active Not Recruiting
NCT04417595Phase 2

Omega-3 Fatty Acids for Smoking Cessation in Pregnancy

Completed
NCT07517003Not Applicable

Sunflower and Olive Oils for Preventing Diaper Dermatitis in Hospitalized Infants

Completed
NCT05465252Not Applicable

Effect of Omega-3 Fatty Acid Supplementation on Dry-AMD Progression

Recruiting
NCT01624792Not Applicable

Eicosapentaenoic Acid and Protein Modulation to Induce Anabolism in Chronic Obstructive Pulmonary Disease (COPD): Aim 2

Completed
NCT06570889Phase 3

VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma

Recruiting
NCT01442480Not Applicable

Cardioprotective Effects of Omega-3 Fatty Acids Supplementation in Healthy Older Subjects Exposed to Air Pollution Particles

Completed
NCT06880939Not Applicable

Antarctic Krill Oil Functional Food Mitigates Bladder Cancer Treatment Side Effects

Not Yet Recruiting
NCT06880926Phase 2

Antarctic Krill Oil for Knee Osteoarthritis Pain

Not Yet Recruiting
NCT06677658

The Role of Olive Oil in the Treatment of Covid-19 Pneumonia

Completed
NCT03399331Phase 1

Honey or Olive Oil for Treating Oral Mucositis in Children and Adults With Leukemia Receiving Intensive Chemotherapy

Completed
NCT04828447Not Applicable

Recipe for Heart Health

Completed
NCT01888211Not Applicable

Effect of Omega 3 Fatty Acids on Vascular Function

Completed
NCT06210230Not Applicable

Double-blind and Placebo-controlled Study on Intervention Effect of Medium and Long Chain Fatty Acid Triglyceride on Glycolipid Homeostasis in Patients With Metabolic Syndrome and Mechanisms

Completed
NCT06058559Not Applicable

Effect of Sunflower Lecithin Supplementation on Meibomian Gland Function in Adults With Dry Eye Disease

Completed
NCT06254118Phase 4

Treatment of Periodontitis in Menopausal Patients

Completed
NCT06188000Not Applicable

Efficacy of Extra Virgin Olive Oil (EVOO) Supplementation on Hand-Foot Syndrome Incidence in Patients With Capecitabine

Unknown
NCT04397055Not Applicable

Oil Consumption and Cholesterol

Completed
NCT05815849Not Applicable

Effect of Enteral Olive Oil Supplement On Weight Gain and Development of Some Complications in Preterm

Completed
NCT05427604Not Applicable

To Evaluate the Effects of Omega 3 Fatty Acids in the Context of Cancer Prevention

Completed

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
80